Shares of StemCells,
Inc.(NASDAQ:STEM) shares ended higher by 1.38% to $2.20, well off session high
of $2.67, which was its new 52-week high.
The company reported
positive result of spinal cord injury treatment by neural stem cells and that
has suddenly increased the unit stock value of StemCells Inc. Extensive study
and research on the benefits of stem cell preservation was going on since last
few years and as per the latest report on the ongoing research the researchers
has expressed satisfactory progress on stem cell therapy for treatment of many
complicated physical injury.
How
Should Investors Trade STEM Now? Find Out Here
Now let’s take a look
on the new research result, regarding stem cell related treatment. StemCells
Inc has started running their clinical Trial lab at Switzerland and here the
target patients were three numbers of patients who were victim of chest level
spinal cord injuries. These patients had total numbness below the injury spot
and totally unresponsive by medicine. Latest study is done neuro stem cell
treatment therapy against complicated spinal cord injury. Not only this therapy
has proved safe and efficient, it has received positive response form 2
patients out of three patients as these two patients have reported improved
sensation after this therapy is applied.
The result has been
presented before International Spinal Cord Society in London at the time of
their annual meeting.
Let’s take a look on
the enormous possibilities peeing out of this research and experiment.
Based on the study of
Stem Cells Inc., The Newark Company of California, has started developing
therapy planning for treatment of spinal cord injury for victims based on adult
neuro stem cells. Stem Cells taken from liver are also being tasted for
preclinical studies although the whole research is based on experiments and
result based hypothesis.
Since July 17, the company has declared
its positive research result on animal-model Alzheimer's disease its share price
has almost doubled, which has created a strong focus in investors’ choice in
stock market investment.
No comments:
Post a Comment